A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
Clinical trial NCT07146906 · RECRUITING
Trial details
- NCT number
- NCT07146906
- Sponsor
- Novartis Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-26
- Primary completion
- 2030-07-12
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.